Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET

Nuclear Medicine and Biology

Volumn 35, Issue 2, 2008, Pages 171-176

  Tsuchida, Tatsuro ^a   Takeuchi, Hiroaki ^a   Okazawa, Hidehiko ^a   Tsujikawa, Tetsuya ^a   Fujibayashi, Yasuhisa ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

1 11C acetate; 18F FDG; Glioma; Grading; Positron emission tomography

Indexed keywords

ACETIC ACID C 11; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BODY WEIGHT; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; INFORMATION PROCESSING; MALE; POSITRON EMISSION TOMOGRAPHY;

ACETATES; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CEREBRAL CORTEX; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 38849114267     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.11.004     Document Type: Article

References (23)

1. Gambhir S.S., Czermin J., Schwimmer J., Silvermann D.H.S., Coleman R.E., and Phelps M.E. A tabulated summary of the FDG PET literature. J Nucl Med 42 Suppl (2001) 1S-71S
2. Coleman R.E., Hoffman J.M., Hanson M.W., Sostman H.D., and Schold S.C. Clinical application of PET for the evaluation of brain tumors. J Nucl Med 32 (1991) 616-622
3. DiChiro G. Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 22 (1986) 360-371
4. Grosu A.L., Piert M., Weber W.A., Jeremic B., Picchio M., Schratzenstaller U., et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 181 (2005) 483-499
5. Wong T.Z., Westhuizen G.J., and Coleman R.E. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 12 (2002) 615-626
6. Spence A.M., Mankoff D.A., and Muzi M. Positron emission tomography imaging of brain tumors. Neuroimag Clin N Am 13 (2003) 717-739
7. 11C-methionine. AJNR Am J Neuroradiol 17 (1996) 345-353
8. Kaschten B., Stevenaert A., Sadzot B., Deprez M., Degueldre C., Del Fiore G., et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 39 (1998) 778-785
9. Sasaki M., Kuwabara Y., Yoshida T., Nakagawa M., Fukushima T., Mihara F., et al. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 25 (1998) 1261-1269
10. Ohtani T., Kurihara H., Ishiguchi S., Saito N., Oriuchi N., Inoue T., et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 28 (2001) 1664-1670
11. 11C acetate. Eur J Nucl Med Mol Imaging 33 (2006) 420-427
12. Yoshimoto M., Waki A., Yonekura Y., Sadato N., Murata T., Omata N., et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol 28 (2001) 114-122
13. Kleihues P., Burger P.C., and Scheithauer B.W. Histological typing of tumors of the central nervous system. World Health Organization international classification of tumors (1993), Springer, Berlin
14. DeGrado T.R., Turkington T.G., Willimas J.J., Stearns C.W., Hoffman J.M., and Coleman R.E. Performance characteristics of whole-body PET scanner. J Nucl Med 35 (1994) 1398-1406
15. 11C](2H3) acetate for in vivo studies of myocardium using PET. Nucl Med Biol 21 (1994) 1067-1072
16. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27 (1986) 235-238
17. Dienel G.A., Popp D., Drew P.D., Ball K., Krisht A., and Cruz N.F. Preferential labeling of glial and meningial brain tumors with [2-14C]acetate. J Nucl Med 42 (2001) 1243-1250
18. Hustinx R., Smith R.J., Benard F., Bhatnagar A., and Alavi A. Can the standardized uptake value characterize primary brain tumors on FDG-PET?. Eur J Nucl Med 26 (1999) 1501-1509
19. Patano P., Baron J.C., Lebrun-Grandie P., Duquesnoy N., Bousser M.G., and Comar D. Regional cerebral blood flow and oxygen consumptions in human aging. Stroke 15 (1984) 635-641
20. Martin A.J., Friston K.J., Colebatch J.G., and Frackowiak R.S. Decrease in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab 11 (1991) 684-689
21. Greenberg H.S., Chandler W.F., and Sandler H.M. Brain tumors (1999), Oxford University Press, New York 58-77
22. Waniewski R.A., and Martin D.L. Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci 18 (1998) 5225-5233
23. Ginsberg L.E., Fuller G.N., Hashmi M., Leeds N.E., and Schomer D.F. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 49 (1998) 436-440